Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Slothman2on Feb 17, 2018 1:41pm
325 Views
Post# 27577834

RE:Will ACB get to $15 again?

RE:Will ACB get to $15 again?Current valuations of marijuana stocks are too high based on their annual sales and production runs. No investor whether it be Joe Blow on Stockhouse, or BMO actually cares about current valuations, they care about where this will lead in 5 years or 10 years. ACB will clearly hit $15 again and it will soon surpass that mark just as soon as everyone holding CMED gets their shares converted, have ACB pump up the share price as most people will be buying again, and then dump them on the open market some time prior to legalization. It will go passed $15 and somewhere in the neighborhood of $18, in my opinion. 

If you read analyst expectations on just about any stock there will be about half that are bullish, half that are bearish, and then there will be the one guy that rates whatever stock a hold. Aurora will go back up to $15 just as soon as it's done with the CMED acquisition and done getting shorted. 
Bullboard Posts